Champions Oncology, Inc. (2I3)
Market Open
15 Jun, 15:05
XSTU 
€
5. 60
+0.05
+0.9009%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.59 Eps
€ 5.55
Previous Close Want to track 2I3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.09 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
2I3 Earnings Reports FAQ
What is the earnings per share (EPS) for 2I3?
The current EPS is -0.59.
What is the company's earnings growth rate?
Champions Oncology, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Champions Oncology, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Champions Oncology, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 2I3 at this time, as Champions Oncology, Inc has no recent EPS data to calculate it.
